• Product NameVarenicline Tartrate
• Brief DescriptionInhibitors
• Purification99.90%
• Biological ActivityVarenicline Tartrate is a nicotinic AChR partial agonist, used to treat nicotine addiction.
• Target NameAChR antagonist
• CAS No. 375815-87-5
• Calculated MW 361.35
• Formulation C13H13N3C4H6O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C1C2CNCC1C3=CC4=NC=CN=C4C=C23.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
  Pathways:Neuroscience
  Receptor:mAChR
  Boling pt:400.6C
  Melting pt:206-208C
  Solubility:Water: 72 mg/mL (199.25 mM); DMSO: 1 mg/mL (2.76 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Rollema H, et al. Neuropharmacology, 2007, 52(3), 985-994.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting